ArticleBMC geriatrics2023

A 71-year-old male with a life-threatening recurrence of hemolytic anemia, thrombocytopenia, and acute kidney injury after pembrolizumab therapy: a case report.

Xin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.